Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Real-world overall survival comparison between first-line Bruton tyrosine kinase inhibitors in treating chronic lymphocytic leukemia/small lymphocytic lymphoma: An analysis of Veterans Health Administration data.
Journal: Journal of managed care & specialty pharmacy
Published: December 03, 2025
Healthcare cost comparison between first-line ibrutinib and acalabrutinib in chronic lymphocytic leukemia patients in the Veterans Affairs.
Journal: Journal of comparative effectiveness research
Published: October 14, 2025
The preclinical discovery and development of zanubrutinib for the treatment of chronic lymphocytic leukemia.
Journal: Expert opinion on drug discovery
Published: February 08, 2025
Could protein kinase inhibitors become a next generation pharmacotherapy for non-Hodgkin's lymphoma?
Could protein kinase inhibitors become a next generation pharmacotherapy for non-Hodgkin's lymphoma?
Journal: Expert opinion on pharmacotherapy
Published: May 10, 2024
EBV-Positive Classic Hodgkin Lymphoma and Primary Nodal T-Cell/NK-Cell Lymphoma Arising in the Background of Follicular Lymphoma.
Journal: Case reports in hematology
Published: April 08, 2024
Neuromuscular electrical stimulation for physical function maintenance during hematopoietic stem cell transplantation: Study protocol.
Journal: PloS one
Published: October 20, 2023
Pilot clinical trial of macimorelin to assess safety and efficacy in patients with cancer cachexia.
Journal: Journal of cachexia, sarcopenia and muscle
Published: April 01, 2022
The evidence to date on umbralisib for the treatment of refractory marginal zone lymphoma and follicular lymphoma.
Journal: Expert opinion on pharmacotherapy
Published: February 25, 2022
Weight Loss in Cancer Patients Correlates With p38β MAPK Activation in Skeletal Muscle.
Journal: Frontiers in cell and developmental biology
Published: September 27, 2021
Last Updated: 09/26/2026